Implanting cardiac rhythm devices during uninterrupted warfarin therapy: a prospective, single center experience

Martino Crosato1, Vittorio Calzolari, Enrico Franceschini Grisolia

  • 1aDivision of Cardiology, Ospedale Civile di Treviso 'Ca' Foncello', Treviso bDivision of Cardiology, Ospedale di Cesena 'Bufalini', Cesena, Italy.

Insights

Cardiac rhythm device implantation is safe without interrupting warfarin therapy. This study found no increased bleeding risk in patients on uninterrupted warfarin compared to those who stopped the medication before their procedure.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Medical Device Implantation

Background:

  • Oral anticoagulant therapy, particularly warfarin, is crucial for patients with high thromboembolic risk.
  • Traditional practice often involves interrupting warfarin before cardiac rhythm device implantation, increasing stroke risk.
  • Assessing the safety of uninterrupted warfarin during these procedures is vital for patient management.

Purpose of the Study:

  • To evaluate the safety of implanting cardiac rhythm devices (pacemakers, defibrillators) while patients remain on uninterrupted warfarin.
  • To compare bleeding complication rates between patients undergoing device implantation on uninterrupted warfarin versus those who stopped warfarin.

Main Methods:

  • A comparative study involving 191 patients undergoing cardiac rhythm device implantation.
  • The 'on warfarin group' (n=102) had procedures during uninterrupted warfarin therapy.
  • The 'off warfarin group' (n=89) underwent procedures after warfarin withdrawal; this group included lower-risk patients for comparison.

Main Results:

  • No significant difference in hematoma incidence (5% vs. 3%, P=not significant) between the 'on warfarin' and 'off warfarin' groups.
  • All hematomas observed were minor and resolved spontaneously.
  • There were no instances of death, hemothorax, tamponade, or significant bleeding complications in either group; no thromboembolic events occurred within 2 months.

Conclusions:

  • Cardiac rhythm device implantation can be safely performed without interrupting warfarin therapy in high-risk patients.
  • Uninterrupted warfarin does not appear to increase the risk of significant bleeding complications compared to warfarin interruption.
  • This approach may help mitigate thromboembolic risks associated with discontinuing anticoagulation.
Abstract

Related Concept Videos

Pulse rhythm01:30

Pulse rhythm

Pulse rhythm refers to the pattern of pulsations within specific intervals, offering valuable insights into the regularity or irregularity of the heart's beats as observed through the pattern of pulsation within specific intervals. A regular pulse exhibits a consistent heart rate with uniform waveforms and pulsation force, variations of which can be classified as normal, weak, or bounding.
Conversely, an irregular pulse pattern is termed dysrhythmia, stemming from disruptions in cardiac...
1.7K
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
595
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.2K
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
5.2K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
746